Hikma Pharmaceuticals PLC

H5P

Company Profile

  • Business description

    Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

  • Contact

    1 New Burlington Place
    LondonW1S 2HR
    GBR

    T: +44 2073992760

    E: [email protected]

    https://www.hikma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    9,400

Stocks News & Analysis

stocks

Oracle earnings: Solid execution secures revenue target and mitigates investor concerns

We raise our fair value estimate for Oracle stock.
stocks

US dividend shares are getting a boost from the HALO trade. Can it last?

Both high-dividend stocks and dividend-growth stocks are outperforming amid AI disruption.
stocks

Unconventional wisdom: A modern day bank run

Is the economy and investor portfolios at risk from a potential ‘bank run’ in private credit?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,839.1026.300.30%
CAC 407,911.53145.83-1.81%
DAX 4023,447.29142.36-0.60%
Dow JONES (US)46,558.47119.38-0.26%
FTSE 10010,261.1544.00-0.43%
HKSE25,465.60251.16-0.98%
NASDAQ22,105.36206.62-0.93%
Nikkei 22553,819.61633.35-1.16%
NZX 50 Index13,187.3411.95-0.09%
S&P 5006,632.1940.43-0.61%
S&P/ASX 2008,617.1029.200.34%
SSE Composite Index4,095.4533.65-0.82%

Market Movers